Concurrent transmission of Zika virus during the 2023 dengue outbreak in Dhaka, Bangladesh
PLoS neglected tropical diseases,
Journal Year:
2025,
Volume and Issue:
19(1), P. e0012866 - e0012866
Published: Jan. 30, 2025
Background
During
the
2023-dengue
outbreak
in
Bangladesh,
a
diagnostic
evaluation
study
was
conducted
to
investigate
concurrent
Zika
virus
(ZIKV)
and
dengue
(DENV)
transmission
Dhaka
2023.
Aims
The
explored
simultaneously
detect
presence
of
ZIKV,
DENV,
and/or
CHIKV
while
considering
relevant
clinical
epidemiological
risk
factors,
using
real-time
multiplex
RT-PCR
system.
Following
this,
it
planned
sequence
selected
samples
identify
genetic
variations
ZIKV
infections
within
population.
Methods
This
designed
as
evaluation,
where
participants
meeting
inclusion
criteria
were
prospectively
recruited
with
written
informed
consent.
A
total
399
febrile
individuals
screened,
185
having
fever
onset
2–5
days,
along
one
following
features,
e.g.
headache,
myalgia,
arthralgia
or
bone
pain,
rash,
nausea,
vomiting,
diarrhea
152
undergoing
testing.
Results
Five
ZIKV-positive
cases
identified,
including
DENV-ZIKV
co-infection.
Phylogenetic
analysis
revealed
strains
part
Asian
lineage,
closely
related
Cambodian
Chinese
from
2019.
All
male,
residing
one-kilometer
radius,
no
prior
travel
history,
suggesting
community-level
transmission.
Conclusion
marks
first
identification
city
report
ZIKV-DENV
co-infection
Bangladesh
that
highlights
challenges
posed
by
symptomatic
similarities
between
other
arboviruses
underscores
need
for
enhanced
surveillance
public
health
interventions
mitigate
spread
impact
dengue-endemic
regions.
Language: Английский
A Narrative Review on the Pandemic Zoonotic RNA Virus Infections Occurred During the Last 25 Years
Journal of Epidemiology and Global Health,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 8, 2024
Pandemic
zoonotic
RNA
virus
infections
have
continued
to
threaten
humans
and
animals
worldwide.
The
objective
of
this
review
was
highlight
the
epidemiology
socioeconomic
impacts
pandemic
that
occurred
between
1997
2021.
Literature
search
done
from
Web
Science,
PubMed,
Google
Scholar
Scopus
databases,
cumulative
case
fatalities
individual
viral
infection
calculated,
geographic
coverage
pandemics
were
shown
by
maps.
Seven
major
2021
presented
in
three
groups:
first
group
consists
highly
pathogenic
avian
influenza
(HPAI-H5N1)
swine-origin
(H1N1)
viruses
with
fatality
rates
53.5%
0.5%
humans,
respectively.
Moreover,
HPAI-H5N1
caused
90–100%
death
poultry
economic
losses
>$10
billion
Similarly,
H1N1
a
serious
swine
0.5-1.5%
Gross
Domestic
Product
(GDP)
affected
countries.
second
severe
acute
respiratory
syndrome-associated
coronavirus
(SARS-CoV),
Middle
East
Respiratory
Syndrome
(MERS-CoV)
Coronavirus
disease
2019
(COVID-19)
9.6%,
34.3%
2.0%,
respectively
humans;
but
only
mild
animals.
third
Ebola
Zika
39.5%
0.02%,
causing
Similar
are
expected
near
future,
hence
strict
implementation
conventional
biosecurity-based
measures
development
efficacious
vaccines
would
help
minimize
next
infection.
Language: Английский
Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome
He Song,
No information about this author
Shihui Jin,
No information about this author
Bing Yang
No information about this author
et al.
Vaccine,
Journal Year:
2025,
Volume and Issue:
48, P. 126728 - 126728
Published: Jan. 16, 2025
Language: Английский
Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin
Cory Hewitt,
No information about this author
Nicholas Wixon,
No information about this author
Arthur Gallegos
No information about this author
et al.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(1), P. 79 - 79
Published: Jan. 16, 2025
Background/Objectives:
Zika
virus
(ZIKV)
infection
is
associated
with
life-threatening
diseases
in
humans.
To
date,
there
are
no
available
FDA-approved
therapies
or
vaccines
for
the
specific
treatment
prevention
of
ZIKV
infection.
Variation
envelope
protein
(Env),
along
its
complex
quaternary
structure,
presents
challenges
to
synthetic
approaches
developing
an
effective
vaccine
and
broadly
neutralizing
antibodies
(bnAbs).
We
hypothesized
that
beta-cyclodextrin
(BCD)
could
be
used
uniquely
inactivate
infectious
without
disruption
Env.
Methods:
was
propagated
Vero
cells
admixed
BCD.
The
BCD-treated
evaluated
infectivity
using
immunofluorescence
quantitative
RT-PCR
(qRT-PCR)
assays,
immunoreactivity
Western
blots,
structural
integrity
by
electron
microscopy,
immunogenicity
mice.
Results:
Here,
we
show
200
mM
non-infectious
cell
culture,
remains
immunoreactive
Env-specific
antibody,
retains
virion
shape
size,
elicits
production
immunogen-specific
immunized
Conclusions:
These
results
indicate
BCD
can
safely
ZIKV,
they
provide
insights
antibody
development.
Language: Английский
Discovery of Arylfuran and Carbohydrate Derivatives from the BraCoLi Library as Potential Zika Virus NS3pro Inhibitors
Fernanda Kelly Marcelino e Oliveira,
No information about this author
Beatriz Murta Rezende Moraes Ribeiro,
No information about this author
Ellen Gonçalves de Oliveira
No information about this author
et al.
Future Pharmacology,
Journal Year:
2025,
Volume and Issue:
5(1), P. 9 - 9
Published: Feb. 15, 2025
Background/Objectives:
Zika
fever
is
a
disease
caused
by
the
virus
(ZIKV).
Symptomatic
cases
may
be
associated
with
neurological
disorders
in
adults,
as
well
congenital
syndrome
and
other
birth
defects
during
pregnancy.
In
2016,
was
considered
public
health
problem
World
Health
Organization
(WHO),
highlighting
need
to
develop
new
therapies
against
disease.
Currently,
there
no
antiviral
or
vaccine
available
treat
prevent
severe
cases.
Due
lack
of
therapeutics
few
promising
hit
molecules,
we
computationally
screened
well-described
ZIKV
protease
(NS3pro)
drug
target
revisit
small-molecule
database
Brazilian
Compound
Library
(BraCoLi)
select
potential
inhibitors.
Methods:
We
employed
consensus
docking
screening
library
1176
compounds
using
GOLD
DockThor.
selected
28
hits
based
on
predicted
binding
affinity,
only
remnants
three
were
at
time
this
study
for
experimental
validation.
The
evaluated
their
cytotoxic
(CC50)
effective
concentrations
(EC50)
activity
Vero
cells.
Results:
presented
modest
CC50
values
89.15
±
3.72,
>100,
29.67
1.01
μM,
latter,
carbohydrate
derivative,
having
an
EC50
value
>12.5
μM
(~40%
inhibition)
PE243.
Additionally,
essentially
non-toxic
compound,
arylfuran
also
inhibited
NS3pro
IC50
17
but
evidence
acting
through
promiscuous
mechanism
enzyme
inhibition.
Conclusion:
This
highlights
relevance
revisiting
existing
assets
identify
novel
therapeutic
starting
points
ZIKV,
aiming
lead
candidates
future.
Language: Английский
Toll-like receptor response to Zika virus infection: progress toward infection control
npj Viruses,
Journal Year:
2025,
Volume and Issue:
3(1)
Published: March 13, 2025
Infection
with
the
Zika
virus
(ZIKV)
poses
a
threat
to
human
health.
An
improved
understanding
of
host
Toll-like
receptor
response,
disease
onset,
and
viral
clearance
in
vivo
vitro
may
lead
development
therapeutic
or
prophylactic
interventions
against
infections.
Currently,
no
clinically
approved
ZIKV
vaccine
is
available,
highlighting
need
for
its
development.
In
this
study,
we
discuss
progress
vaccine,
including
advances
use
agonists
as
adjuvants
enhance
efficacy.
Language: Английский
Envelope Protein-Targeting Zika Virus Entry Inhibitors
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9424 - 9424
Published: Aug. 30, 2024
Zika
virus
(ZIKV;
family,
Flaviviridae),
which
causes
congenital
syndrome,
Guillain-Barré
Syndrome,
and
other
severe
diseases,
is
transmitted
mainly
by
mosquitoes;
however,
the
can
be
through
routes.
Among
three
structural
seven
nonstructural
proteins,
surface
envelope
(E)
protein
of
ZIKV
plays
a
critical
role
in
viral
entry
pathogenesis,
making
it
key
target
for
development
effective
inhibitors.
This
review
article
describes
life
cycle,
genome,
encoded
proteins
ZIKV,
illustrates
structure
function
E
protein,
summarizes
protein-targeting
inhibitors
(with
focus
on
those
based
natural
products
small
molecules),
highlights
challenges
that
may
potentially
hinder
infection.
Overall,
will
provide
useful
guidance
further
safe
potent
targeting
protein.
Language: Английский
Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice
Vaccine,
Journal Year:
2024,
Volume and Issue:
42(25), P. 126213 - 126213
Published: Aug. 12, 2024
Language: Английский
Concurrent Transmission of Zika Virus During the 2023 Dengue Outbreak in Bangladesh
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 2, 2024
Abstract
Background
During
the
2023-dengue
outbreak
in
Bangladesh,
a
diagnostic
evaluation
study
was
conducted
to
investigate
concurrent
Zika
virus
(ZIKV)
and
dengue
(DENV)
transmission
Dhaka
2023.
Aims
The
explored
simultaneously
detect
presence
of
ZIKV,
DENV,
and/or
CHIKV
while
considering
relevant
clinical
epidemiological
risk
factors,
using
real-time
multiplex
RT-PCR
system.
Following
this,
it
planned
sequence
selected
samples
identify
genetic
variations
ZIKV
infections
within
population.
Methods
This
designed
as
evaluation,
where
participants
meeting
inclusion
criteria
were
prospectively
recruited
with
written
informed
consent.
A
total
399
febrile
individuals
screened,
185
having
fever
onset
2
–
5
days,
along
one
following
features,
e.g.
headache,
myalgia,
arthralgia
or
bone
pain,
rash,
nausea,
vomiting,
diarrhea
152
undergoing
testing.
Results
Five
ZIKV-positive
cases
identified,
including
DENV-ZIKV
co-infection.
Phylogenetic
analysis
revealed
strains
part
Asian
lineage,
closely
related
Cambodian
Chinese
from
2019.
All
male,
residing
one-kilometer
radius,
no
prior
travel
history,
suggesting
community-level
transmission.
Conclusion
marks
first
identification
city
report
ZIKV-DENV
co-infection
Bangladesh
that
highlights
challenges
posed
by
symptomatic
similarities
between
other
arboviruses
underscores
need
for
enhanced
surveillance
public
health
interventions
mitigate
spread
impact
dengue-endemic
regions.
Synopsis
explores
co-transmission
during
2023
shedding
light
on
important
issues.
While
is
typically
mild
illness
most
people,
can
have
serious
neurological
consequences,
such
microcephaly
infants.
Dengue,
another
mosquito-borne
common
tropical
regions
like
affects
significant
portion
research
stands
out
because
recorded
instance
Zika-Dengue
country.
discovery
crucial
both
local
global
communities,
challenge
managing
outbreaks
similar
viruses
at
same
time,
complicating
diagnosis
treatment.
calls
stronger
better
measures
manage
these
viruses,
particularly
densely
populated
areas
illnesses
rapidly.
work
focuses
importance
raising
awareness
enhancing
disease
management
practices
reduce
risks
infections.
overlap
symptoms
potentially
outcomes
vulnerable
groups,
pregnant
women
newborns,
make
understanding
Zika’s
critical.
These
insights
guide
future
efforts
vaccine
development
community
level.
Language: Английский